000 01642 a2200433 4500
005 20250512005201.0
264 0 _c19891017
008 198910s 0 0 eng d
022 _a0014-2980
024 7 _a10.1002/eji.1830190822
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchleuning, M J
245 0 0 _aInhibition by chlorpromazine of lymphokine-specific mRNA expression in human thymocytes.
_h[electronic resource]
260 _bEuropean journal of immunology
_cAug 1989
300 _a1491-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aChlorpromazine
_xpharmacology
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aGene Expression Regulation
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aInositol Phosphates
_xmetabolism
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aLymphokines
_xgenetics
650 0 4 _aPhosphatidylinositols
_xmetabolism
650 0 4 _aProtein Kinase C
_xphysiology
650 0 4 _aProto-Oncogene Mas
650 0 4 _aProto-Oncogene Proteins
_xgenetics
650 0 4 _aProto-Oncogene Proteins c-myc
650 0 4 _aRNA, Messenger
_xgenetics
650 0 4 _aReceptors, Interleukin-2
_xgenetics
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aThymus Gland
_xcytology
650 0 4 _aTranscription, Genetic
_xdrug effects
700 1 _aDuggan, A
700 1 _aReem, G H
773 0 _tEuropean journal of immunology
_gvol. 19
_gno. 8
_gp. 1491-5
856 4 0 _uhttps://doi.org/10.1002/eji.1830190822
_zAvailable from publisher's website
999 _c2556204
_d2556204